Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 406 (OTC: $CSUI)
(TSXV: $SUGR.V) (OTC: $RLLRF) (TSXV: $EMH.V) (OTCQX: $EMHTF)
Delta, Kelowna, BC, April 29, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s
podcast will be looking at a few public company announcements as well as state
and city regulatory changes in the works.
To
differentiate itself from other Cannabis based companies, Cannabis Suisse Corp (OTC:
CSUI) announced
creating some new cannabis products, their Alpine Cannabis Hemp Extract Oils..
CBD-related
products have been increasingly popular over the recent few years. And it's
been happening for a reason. CBD doesn't get users high and has an ability to
treat multiple conditions and diseases. Apart from that, the U.S. DEA has
officially removed the CBD with little to no THC from their list of controlled
substances.
Cannabis
Suisse’s high-grade cannabis oil will be sold in concentrations of 10%, 15%,
and 25% CBD. It is produced in Switzerland and supplied to both medical and
recreational vendors. However, there are some market and legal restrictions
that may apply outside of Switzerland.
Cannabidiol,
also known as CBD, oil can be obtained from Cannabis plants along with over 100
other compounds. It is widely used in therapeutics and is known to ease the
symptoms of anxiety, epilepsy and even cancer.
As
of now, the most significant research confirms positive effects of CBD oil for
patients experiencing seizures (https://www.nature.com/articles/s41598-019-44056-y).
Scientists tend to believe that CBD oil helps repress seizures by slowing down
signals that are sent to the brain and by changing levels of calcium in brain
cells thus decreasing inflammation in the brain. Some studies suggest that CBD
may help with diabetes, heart diseases, substance abuse, mental disorders and
certain types of cancers. CBD can have a beneficial effect on the skin due to
anti-inflammatory properties and the ability to control skin pores and glands.
Sugarbud Craft
Growers Corp. (TSXV:
SUGR) (OTC:
RLLRF) announced that as
part of the previously announced third-party licensing and distribution
agreement with Agro-Greens Natural Products Ltd. it will officially launch its
Craft Cannabis Collection of adult use recreational cannabis products on June
23, 2020.
Sugarbud
also announced that it has filed and been receipted for a preliminary
short-form prospectus with the securities regulatory authorities in all
provinces of Canada (except Québec) in connection with a commercially
reasonable "best efforts" marketed public offering of secured
convertible debenture units at a price of $1,000 per Debenture Unit for gross
proceeds of up to a maximum of $4.0 million. Mackie Research Capital
Corporation will act as sole book-runner and agent in respect of the Offering.
"Comprised
of some of the most exquisite and exclusive strains, the Sugarbud Craft
Cannabis Collection promises to deliver an exceptional experience to even the
most discerning of customers," stated Sugarbud CEO, John Kondrosky. "In addition to the consistency of our
flower, we view potency and terpene profiles to be a very strong indicator of
quality and, based upon our results to date, we could not be more thrilled with
what we have currently in our new product pipeline," continued Mr.
Kondrosky. "Our operating and cultivation teams continue to execute
extremely well and in a manner consistent with our vision to deliver superior products
to legal markets in Canada. With an average total THC value of 23.6%1
across our entire first harvest, we view the results we have achieved to date
as a clear indication of superior outcomes and we have every reason to believe
that our approach to the cultivation of ultra-premium craft cannabis will
consistently deliver on our commitment to quality and an exceptional consumer
experience," continued Mr. Kondrosky.
"The
launch of the Sugarbud Craft Cannabis Collection and our entry into the
recreational cannabis market in Canada represents both a pivotal and
transformational catalyst for growth and value creation for Sugarbud,"
concluded Mr. Kondrosky.
Emerald Health
Therapeutics, Inc. (TSXV:
EMH)
(OTCQX:
EMHTF) announced its new
nanoemulsion-based Fast Action Spray product line, an important step in
Emerald’s Cannabis 2.0 strategy and a unique offering in the Canadian cannabis
marketplace. This unique formulation offers notable advantages over existing
formats of cannabis consumption in terms of convenience and predictability of
consumption. The product line will consist of CBD and THC cannabinoids mixed
with specific terpenes and flavorings. The first product is planned for launch
in June.
Emerald’s
first product is a CBD 12.5 mg/mL + myrcene combination that it expects to
launch for medical users in June. Additional products include a CBD 15 mg/mL
lemon + limonene combination and a THC 15 mg/mL citrus + limonene combination,
expected to be launched in July into adult-use channels. Emerald has chosen to
add specific all-natural terpenes to its nanoemulsion product line: myrcene has
been shown to have anti-inflammatory, analgesic, and anxiolytic properties;
limonene has been shown to have anti-inflammatory, analgesic, antioxidant,
antidepressant and immunostimulating attributes*. Emerald is also developing
“flavour-masked” versions, which will have significantly less cannabis flavour.
All of the Fast Action Spray products will be packaged in 15 mL bottles.
“This
is a game-changing new product category for the Canadian cannabis marketplace,”
said Riaz Bandali, President & CEO of Emerald. “Our nanoemulsion product
line offers convenience, predictability, no odour, and attractive value
relative to the amount of absorbable active ingredient. We believe these
products offer both medical and adult-use consumers a tremendously advantageous
choice compared to inhaled or edible products to achieve desired outcomes from
cannabis. We are pleased with the interest from cannabis distribution boards in
multiple provinces that we have experienced about this new product and look
forward to soon launching this line.”
Lastly
we look at regulations, the section of the industry that is facing a lot of
change and pushback as this pandemic continues.
In
recent
news in Denver, a new working group whose membership
comprises of marijuana industry and community stakeholders aims to have the
City of Denver's ear on pot licensing issues such as weed delivery and
hospitality businesses.
In an April 27 memo sent to
marijuana business owners in Denver, the Denver Department of Excise and
Licenses described the Marijuana Licensing Work Group, a 24-person advisory
board that will "review, discuss and make recommendations on policy
direction and possible marijuana licensing laws, rules and regulation,"
according to the announcement.
The MLWG will
review licensing opportunities granted by two
new laws allowing pot delivery and social consumption businesses in
Colorado. Both laws require local approval before such services are allowed
within a municipality's borders, and the working group has been a planned step
in Denver's exploration of the new opportunities.
Virtual meetings
are currently scheduled to take place May 14, May 28, June 11 and June 25 on
Zoom to avoid human interaction during the COVID-19 pandemic; those online
meetings are open to the public.
This is not the
only regulatory change in the works and I would recommend Cannabis
Business Times for more updated news regarding state by
state regulation changes during the COVID-19 Pandemic.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and
equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Disclosure: CSUI is a paid monthly news and social media
cannabis company on Investorideas.com Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
No comments:
Post a Comment